Cost-consequence models for outcomes research and managed care Newsletter Article 17 February 2013 Pages: 2 - 2
Don’t forget drug costs when making prescribing decisions Newsletter Article 17 February 2013 Pages: 5 - 5
Treatment patterns and healthcare costs in HIV infection Newsletter Article 17 February 2013 Pages: 7 - 7
Costs and outcomes of influenza vaccination in healthy adults Newsletter Article 17 February 2013 Pages: 8 - 8
Omeprazole offers cost advantage vs ranitidine for reflux oesophagitis Newsletter Article 17 February 2013 Pages: 9 - 9
Trimetrexate second-line therapy for AIDS-related PCP? Newsletter Article 17 February 2013 Pages: 10 - 10
Financial impact of diabetes mellitus-related amputations Newsletter Article 17 February 2013 Pages: 10 - 11
US study favours omeprazole over ranitidine for oesophagitis Newsletter Article 17 February 2013 Pages: 12 - 12
Calcium antagonists’ cost-saving potential in renal transplantation Newsletter Article 17 February 2013 Pages: 12 - 12
Autologous BMT not justified for non-Hodgkin’s lymphoma Newsletter Article 17 February 2013 Pages: 13 - 13
Treatment not sought because of prescription charges Newsletter Article 17 February 2013 Pages: 14 - 14
Italian national drug formulary ‘undoubtedly useful’ Newsletter Article 17 February 2013 Pages: 14 - 15
Few managed care plans would reimburse OTC nicotine gum Newsletter Article 17 February 2013 Pages: 15 - 15
